Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors

✍ Scribed by Yutaka Ueda; Tatsu Shimoyama; Haruyasu Murakami; Noboru Yamamoto; Yasuhide Yamada; Hitoshi Arioka; Tomohide Tamura

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 472 KB
• Volume: 67
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-010-1404-z